Works matching IS 19466234 AND DT 2015 AND VI 7 AND IP 275
Results: 6
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 275, p. 1, doi. 10.1126/scitranslmed.aaa4963
- By:
- Publication type:
- Article
(Re)solving atherosclerosis.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 275, p. 1, doi. 10.1126/scitranslmed.aaa5355
- By:
- Publication type:
- Article
Joining forces to drive biomedical translation.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 275, p. 1, doi. 10.1126/scitranslmed.3010329
- By:
- Publication type:
- Article
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 275, p. 1, doi. 10.1126/scitranslmed.aaa1065
- By:
- Publication type:
- Article
Regulation of immune responses to protein therapeutics by transplacental induction of T cell tolerance.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 275, p. 1, doi. 10.1126/scitranslmed.aaa1957
- By:
- Publication type:
- Article